Mika J Välimäki

9PUBLICATIONS
15CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursNeurology and neuromuscular diseasesMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
Genotype-Dependent Effects of Mechanical Stretch and GATA4-Targeted Compound 3i-1262 in Cardiomyopathy Patient-Derived hiPSC-Cardiomyocytes.

|Mar 28, 2025
Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach.

Robert S Leigh, Bogac L Kaynak, Heikki Ruskoaho

|Jan 03, 2024
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound.

Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno

|Jun 10, 2021
Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation.

Irena Hlushchuk, Heikki Ruskoaho, Andrii Domanskyi

|Mar 19, 2020
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.

S Tuuli Karhu, Sini M Kinnunen, Marja Tölli

|Aug 22, 2019
Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators.

Mikael Jumppanen, Sini M Kinnunen, Mika J Välimäki

Pageof 2

Frequent Collaborators

6 joint publications

Heikki Ruskoaho

3 joint publications

Sini M Kinnunen

3 joint publications

Virpi Talman

2 joint publications

Samuli Auno